Table 6 Metabolic and electrolyte disturbances in study groups.

From: Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children

Variables, n (%)

Citrate group % (n = 115)

Heparin group % (n = 165)

p

Hypocalcemia

41 (35.7)

25 (15.2)

< 0.0001

Hypercalcemia

3 (2.6)

0 (0.0)

0.068

Hyponatremia

0 (0.0)

0 (0.0)

NA

Hypernatremia

18 (15.7)

16 (9.7)

0.189

Hypomagnesemia

13 (11.3)

13 (7.9)

0.446

Hypophosphatemia

35 (30.4)

42 (25.5)

0.359

Metabolic alkalosis

38 (33.0)

32 (19.4)

0.009

Citrate accumulation

4 (3.5)

NA

NA